Mia Peptide
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Mia Peptide between 1 Mar 2026 and 26 Jun 2026. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Tentative Rating
Mia Peptide
Retatrutide
Tested 4 Samples
Last test 26 Jun 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Mia Peptide
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
26 Jun 2026
First
1 Mar 2026
| Quantity | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 26 Jun 2026 | View | 10mg | ⚠️ Sample does not contain Retatrutide | n/a | Reta 10 | No label / Silver crimp / Blue cap | Lab G | Public | |||
| 28 Apr 2026 | View | 20mg | 19.6mg | -2.0% | 99.90% | below LOQ | (no batch ID) | No Label / Copper Crimp / Clear Cap | Lab E | Public | |
| 23 Apr 2026 | View | 50mg | 51.1mg | +2.2% | 99.90% | n/a | January 18, 2026 | No Label / Silver Crimp / Clear Yellow Cap | Lab G | Public | |
| 1 Mar 2026 | View | 5mg | 4.5mg | -10.0% | 99.50% | n/a | Dec 08, 2025 | No Label / Silver Crimp / White Cap | Lab G | Public | |